A A A

What is Aducanumab (Aduhelm)?

July 12, 2021

From the desk of guest author Joseph E. Gaugler, PhD, Professor and Robert L. Kane Endowed Chair in Long-Term Care and Aging, School of Public Health

Aducanumab Aduhelm, Laboratory

On June 7, 2021, the Food and Drug Administration (FDA) approved Aducanumab (Aduhelm), the first new drug for Alzheimer’s disease in almost 20 years. Aducanumab is a medication that may help slow the progression of early stage Alzheimer’s disease.

Many people living with dementia, families, and care professionals have questions regarding this news. We’ve compiled a set of frequently asked questions and some answers, to provide you with a better understanding of what to expect with the FDA approval of Aducanumab.

Read the Full Brief: Aducanumab FAQ

Learn more about Joseph E. Gaugler, PhD  

 

Joseph E Gaugler, PhD

About Dr. Gaugler: His research examines the sources and effectiveness of long-term care for persons with Alzheimer's disease and other chronic conditions. An applied gerontologist, Dr. Gaugler's interests include Alzheimer's disease and long-term care, the longitudinal ramifications of family care for persons with dementia and other chronic conditions, and the effectiveness of community-based and psychosocial services for older adults with dementia and their caregiving families.


Schedule a tour

Contact us

Quotes

My mother had Parkinson's disease and lived at Emerald Crest Shakopee during the last few years of her life. She was given so much love, respect and caring by the staff, especially as her disabilities increased and as she required much more care. Our family found Emerald Crest to be a warm and homey environment, and we loved the courtyard available to the residents, and so did my mother. We developed relationships with the staff, residents and even some of the residents' family members. It was truly a warm and caring community. I’d recommend Emerald Crest to others looking for a caring community for their loved ones.

— Tracy, daughter of resident

Quotes

Privacy Policy

 

HIPAA Privacy Notice

icon_equal_housing.pngEqual Housing Opportunity

With a deep knowledge of memory care, we offer specialized assisted living for seniors with Alzheimer’s and dementia-related conditions in the Minneapolis – St. Paul area: Shakopee, Burnsville, Minnetonka. For tours and general information, Contact Us.